We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Study Finds FDA, CMS Regularly Miss Mandatory Review Timelines
Study Finds FDA, CMS Regularly Miss Mandatory Review Timelines
October 12, 2012
The FDA and Centers for Medicare and Medicaid Services (CMS) continue to struggle — and often fail — to meet statutory deadlines for approving Class III devices and issuing national coverage decisions (NCD), according to a paper in the October issue of Health Affairs that looked at median approval times since the mid-1990s.